{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:44:23Z","timestamp":1790837063054,"version":"4.1.0"},"reference-count":90,"publisher":"JLE","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nephro.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T09:22:15Z","timestamp":1434705735000},"page":"201-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyponatr\u00e9mies\u00a0: de la physiopathologie aux traitements. Revue de la litt\u00e9rature pour le clinicien"],"prefix":"10.1684","volume":"11","author":[{"given":"Antoine","family":"Braconnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Vrigneaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Bertocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2015.04.002_bib0460","first-page":"1","article-title":"Les actes de biologies m\u00e9dicale\u00a0: analyse des d\u00e9penses en 2008\u00a0et 2009","author":"Robba","year":"2010","journal-title":"Points Reperes"},{"issue":"7\u00a0Suppl\u00a01","key":"10.1016\/j.nephro.2015.04.002_bib0470","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2006.05.005","article-title":"Incidence and prevalence of hyponatremia","volume":"119","author":"Upadhyay","year":"2006","journal-title":"Am J Med"},{"issue":"10\u00a0Suppl\u00a01","key":"10.1016\/j.nephro.2015.04.002_bib0475","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0480","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cccn.2003.08.001","article-title":"Age and gender as risk factors for hyponatremia and hypernatremia","volume":"337","author":"Hawkins","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.nephro.2015.04.002_bib0485","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjmed.2013.07.021","article-title":"Prevalence of hyponatremia and association with mortality: results from NHANES","volume":"126","author":"Mohan","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra1404489","article-title":"Disorders of plasma sodium \u2013 causes, consequences, and correction","volume":"372","author":"Sterns","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl\u00a02","key":"10.1016\/j.nephro.2015.04.002_bib0495","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.04.002_bib0500","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/jbmr.380","article-title":"Mild hyponatremia as a risk factor for fractures: the Rotterdam Study","volume":"26","author":"Hoorn","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nephro.2015.04.002_bib0505","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1073\/pnas.1318257110","article-title":"Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia","volume":"110","author":"Tamma","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nephro.2015.04.002_bib0510","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.mnh.0000447022.51722.f4","article-title":"Sodium homeostasis and bone","volume":"23","author":"Hannon","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nephro.2015.04.002_bib0515","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11357-011-9347-9","article-title":"Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats","volume":"35","author":"Barsony","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.nephro.2015.04.002_bib0520","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinternmed.2009.513","article-title":"Impact of hospital-associated hyponatremia on selected outcomes","volume":"170","author":"Wald","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0525","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/eurjhf\/hfr086","article-title":"Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure","volume":"13","author":"Balling","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.nephro.2015.04.002_bib0530","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.111.065391","article-title":"Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure","volume":"125","author":"Kovesdy","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.nephro.2015.04.002_bib0535","doi-asserted-by":"crossref","first-page":"e80451","DOI":"10.1371\/journal.pone.0080451","article-title":"Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis","volume":"8","author":"Corona","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nephro.2015.04.002_bib0540","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-7547-4-10","article-title":"Cost of illness of hyponatremia in the United States","volume":"4","author":"Boscoe","year":"2006","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.nephro.2015.04.002_bib0545","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3810\/hp.2013.02.1014","article-title":"Health care utilization, costs, and readmission rates associated with hyponatremia","volume":"41","author":"Deitelzweig","year":"2013","journal-title":"Hosp Pract (1995)"},{"key":"10.1016\/j.nephro.2015.04.002_bib0550","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1681\/ASN.2007070752","article-title":"Medical costs of abnormal serum sodium levels","volume":"19","author":"Shea","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0555","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcn\/33.1.27","article-title":"Total body water volumes for adult males and females estimated from simple anthropometric measurements","volume":"33","author":"Watson","year":"1980","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nephro.2015.04.002_bib0560","series-title":"Physiologie r\u00e9nale et d\u00e9sordres hydro\u00e9lectrolytiques","first-page":"123","article-title":"Bilan de l\u2019eau et osmolalit\u00e9 extracellulaire","author":"Leviel","year":"1997"},{"key":"10.1016\/j.nephro.2015.04.002_bib0565","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1521-690X(03)00049-6","article-title":"Disorders of body water homeostasis","volume":"17","author":"Verbalis","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2015.04.002_bib0570","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1523\/JNEUROSCI.1495-08.2008","article-title":"Amplification of transducer gain by angiotensin\u00a0II-mediated enhancement of cortical actin density in osmosensory neurons","volume":"28","author":"Zhang","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.nephro.2015.04.002_bib0575","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/qjmed\/hcg078","article-title":"Solute loss plays a major role in polydipsia-related hyponatraemia of both water drinkers and beer drinkers","volume":"96","author":"Musch","year":"2003","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.nephro.2015.04.002_bib0580","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2215\/CJN.10741013","article-title":"Osmotic homeostasis","volume":"10","author":"Danziger","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0585","first-page":"E607","article-title":"Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes","volume":"244","author":"Zerbe","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0590","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2400","article-title":"Central mechanisms of osmosensation and systemic osmoregulation","volume":"9","author":"Bourque","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nephro.2015.04.002_bib0595","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuron.2010.12.028","article-title":"The molecular and cellular identity of peripheral osmoreceptors","volume":"69","author":"Lechner","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nephro.2015.04.002_bib0600","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/jcem-42-4-613","article-title":"The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man","volume":"42","author":"Robertson","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2015.04.002_bib0605","series-title":"Seldin and Giebisch's The Kidney","first-page":"1179","article-title":"Hyponatremia","author":"Sterns","year":"2008"},{"key":"10.1016\/j.nephro.2015.04.002_bib0610","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.159.3814.545","article-title":"Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin","volume":"159","author":"Chase","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.nephro.2015.04.002_bib0615","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/357333a0","article-title":"Molecular cloning of the receptor for human antidiuretic hormone","volume":"357","author":"Birnbaumer","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nephro.2015.04.002_bib0620","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbamem.2006.06.001","article-title":"cAMP regulates vasopressin-induced AQP2\u00a0expression via protein kinase A-independent pathway","volume":"1758","author":"Umenishi","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nephro.2015.04.002_bib0625","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2215\/CJN.05760513","article-title":"Collecting duct principal cell transport processes and their regulation","volume":"10","author":"Pearce","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0630","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00418-008-0457-0","article-title":"Localization and trafficking of aquaporin\u00a02\u00a0in the kidney","volume":"130","author":"Takata","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0635","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2215\/CJN.08750812","article-title":"Urine-concentrating mechanism in the inner medulla: function of the thin limbs of the loops of Henle","volume":"9","author":"Dantzler","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl\u00a02","key":"10.1016\/j.nephro.2015.04.002_bib0640","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S1769-7255(07)80017-4","article-title":"Sodium determination in biological fluids","volume":"3","author":"Cristol","year":"2007","journal-title":"N\u00e9phrologie & Th\u00e9rapeutique"},{"key":"10.1016\/j.nephro.2015.04.002_bib0645","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000351804","article-title":"Spurious electrolyte disorders: a diagnostic challenge for clinicians","volume":"38","author":"Liamis","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0650","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMcps031078","article-title":"Clinical problem-solving. Mind the gap","volume":"349","author":"Turchin","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nephro.2015.04.002_bib0655","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ndt\/gfu298","article-title":"Pseudohypernatremia and pseudohyponatremia: a linear correction","volume":"30","author":"Goldwasser","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.04.002_bib0660","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1056\/NEJM198401123100207","article-title":"Current concepts. Serum osmolality. Uses and limitations","volume":"310","author":"Gennari","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0665","series-title":"The kidney","first-page":"540","article-title":"Disorders of water balance","author":"Verbalis","year":"2012"},{"key":"10.1016\/j.nephro.2015.04.002_bib0670","series-title":"Osmolalit\u00e9. Encyclop\u00e9die M\u00e9dico-Chirurgicale \u2013 Biologie M\u00e9dicale","author":"Schmitt","year":"2003"},{"key":"10.1016\/j.nephro.2015.04.002_bib0675","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0002-9343(99)00055-8","article-title":"Hyponatremia: evaluating the correction factor for hyperglycemia","volume":"106","author":"Hillier","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0680","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nephro.2012.10.002","article-title":"Disorders in sodium-water balance","volume":"9","author":"Petitclerc","year":"2013","journal-title":"N\u00e9phrologie & Th\u00e9rapeutique"},{"key":"10.1016\/j.nephro.2015.04.002_bib0685","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00003246-200205000-00016","article-title":"Osmolar gap hyponatremia in critically ill patients: evidence for the sick cell syndrome?","volume":"30","author":"Guglielminotti","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0690","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(97)12169-9","article-title":"Sodium","volume":"352","author":"Kumar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.04.002_bib0695","doi-asserted-by":"crossref","first-page":"G229","DOI":"10.1152\/ajpgi.00424.2013","article-title":"Defining the role of albumin infusion in cirrhosis-associated hyponatremia","volume":"307","author":"Nguyen","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0700","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2012.180","article-title":"The pathophysiology of edema formation in the nephrotic syndrome","volume":"82","author":"Siddall","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.04.002_bib0705","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1681\/ASN.V102323","article-title":"Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease","volume":"10","author":"Vande Walle","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0710","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2013.02.365","article-title":"Thiazide-associated hyponatremia: a population-based study","volume":"62","author":"Rodenburg","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.04.002_bib0715","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2125.2005.02531.x","article-title":"Thiazide diuretic prescription and electrolyte abnormalities in primary care","volume":"61","author":"Clayton","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0720","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1378\/chest.103.2.601","article-title":"Diuretic-induced severe hyponatremia. Review and analysis of 129\u00a0reported patients","volume":"103","author":"Sonnenblick","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.nephro.2015.04.002_bib0725","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/014107689008301111","article-title":"Diuretics and electrolyte disturbances in 1000\u00a0consecutive geriatric admissions","volume":"83","author":"Byatt","year":"1990","journal-title":"J R Soc Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0730","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/14740330903499257","article-title":"Diuretics in clinical practice. Part\u00a0II: electrolyte and acid-base disorders complicating diuretic therapy","volume":"9","author":"Sarafidis","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nephro.2015.04.002_bib0735","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone","volume":"42","author":"Bartter","year":"1967","journal-title":"Am J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0740","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.semnephrol.2009.03.002","article-title":"The treatment of hyponatremia","volume":"29","author":"Sterns","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0745","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.sult.2013.09.009","article-title":"Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis","volume":"35","author":"Alleman","year":"2014","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.nephro.2015.04.002_bib0750","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1681\/ASN.2012020128","article-title":"The challenge of hyponatremia","volume":"23","author":"Adrogue","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0755","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM200005253422107","article-title":"Hyponatremia","volume":"342","author":"Adrogue","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nephro.2015.04.002_bib0760","first-page":"1","volume":"10","author":"Sterns","year":"2011","journal-title":"Nephrology Self-Assesment Program"},{"key":"10.1016\/j.nephro.2015.04.002_bib0765","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrendo.2010.229","article-title":"Vaptans for the treatment of hyponatremia","volume":"7","author":"Robertson","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0770","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.semnephrol.2009.03.005","article-title":"The syndrome of inappropriate secretion of antidiuretic hormone (SIADH)","volume":"29","author":"Decaux","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0775","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000183052","article-title":"Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics","volume":"35","author":"Decaux","year":"1983","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2015.04.002_bib0780","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","article-title":"Lithium nephrotoxicity revisited","volume":"5","author":"Grunfeld","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0785","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM197510302931809","article-title":"Correction of antidiuresis by demeclocycline","volume":"293","author":"De Troyer","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0790","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ageing\/31.2.151-a","article-title":"Irreversible nephrotoxicity from demeclocycline in the treatment of hyponatremia","volume":"31","author":"Curtis","year":"2002","journal-title":"Age Ageing"},{"key":"10.1016\/j.nephro.2015.04.002_bib0795","series-title":"Alkonatrem","author":"ANSM","year":"2015"},{"key":"10.1016\/j.nephro.2015.04.002_bib0800","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.drudis.2010.08.001","article-title":"Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents","volume":"15","author":"Veeraveedu","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nephro.2015.04.002_bib0805","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(99)00530-0","article-title":"In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat","volume":"381","author":"Risvanis","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0810","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nephro.2015.04.002_bib0815","doi-asserted-by":"crossref","first-page":"c62","DOI":"10.1159\/000324653","article-title":"The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options","volume":"119","author":"Esposito","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2015.04.002_bib0820","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2215\/CJN.06990711","article-title":"Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH","volume":"7","author":"Soupart","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0825","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/cncr.28468","article-title":"Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety","volume":"120","author":"Salahudeen","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.nephro.2015.04.002_bib0830","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ndt\/gfp731","article-title":"Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience","volume":"25","author":"Velez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.04.002_bib0835","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0840","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-10-1078","article-title":"Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion","volume":"164","author":"Verbalis","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0845","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","author":"Cardenas","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0850","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0855","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nephro.2015.04.002_bib0860","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.amjcard.2005.10.050","article-title":"Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia","volume":"97","author":"Gheorghiade","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0865","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2015.04.002_bib0870","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/17482940701210179","article-title":"Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and chronic therapeutic impact of a vasopressin antagonist in chronic heart failure (ACTIV in CHF) trial","volume":"9","author":"Rossi","year":"2007","journal-title":"Acute Card Care"},{"key":"10.1016\/j.nephro.2015.04.002_bib0875","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2015.04.002_bib0880","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cardfail.2013.04.001","article-title":"Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan","volume":"19","author":"Hauptman","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.nephro.2015.04.002_bib0885","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","article-title":"A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial","volume":"37","author":"Wong","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2015.04.002_bib0890","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1053\/jhep.2002.36375","article-title":"Pharmacodynamic effects of a nonpeptide antidiuretic hormone\u00a0V2\u00a0antagonist in cirrhotic patients with ascites","volume":"36","author":"Guyader","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2015.04.002_bib0895","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198802183180702","article-title":"Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia","volume":"318","author":"Goldman","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.04.002_bib0900","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.biopsych.2008.06.017","article-title":"Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia","volume":"64","author":"Josiassen","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nephro.2015.04.002_bib0905","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00228-011-1106-4","article-title":"Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects","volume":"68","author":"Shoaf","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2015.04.002_bib0455","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1053\/j.ajkd.2013.01.034","article-title":"Role of vaptans in the management of hyponatremia","volume":"62","author":"Lehrich","year":"2013","journal-title":"Am J Kidney Dis"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725515000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725515000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2015.04.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T19:07:44Z","timestamp":1748459264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725515000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1769725515000863"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2015.04.002","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyponatr\u00e9mies\u00a0: de la physiopathologie aux traitements. Revue de la litt\u00e9rature pour le clinicien","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}